
News & Events
News & Events
-
November 9, 2023
C-Path’s Pioneering Neuroscience Workshop Transforms the Landscape of Neurological Disorder Therapies
TUCSON, Ariz., Nov. 9, 2023 – Critical Path Institute (C-Path) is pleased to announce the release of a new peer-reviewed publication, titled “Transforming Drug Development for Neurological Disorders: Proceedings from a Multi-disease Area Workshop,” now published in Neurotherapeutics, The Journal of the American Society for Experimental Neurotherapeutics. A distinguished team of C-Path scientists and patient-advocates... -
October 24, 2023
Critical Path for Parkinson’s Welcomes New Co-chairs Pagano, Gaetano
Critical Path for Parkinson’s mission is to serve as a leading international consortium convening diverse stakeholders to collectively advance data driven collaborative research aimed at accelerating drug development. The CPP co-director has a unique opportunity for broad visibility and to contribute to advancing regulatory science and encourage collaboration amongst all stakeholders. The benefits to... -
September 20, 2023
The CPP Consortium Welcomes Biohaven as its Newest Member
The Critical Path for Parkinson’s Consortium is excited to welcome Biohaven as its newest member. Biohaven is a biopharmaceutical company aimed at discovering and developing novel life-changing therapies for people living with neurological and neuropsychiatric diseases by collaborating with leaders in scientific discovery and medicine. CPP is excited to work with Biohaven as one of many new members from... -
August 25, 2023
C-Path is pleased to welcome Acurex Biosciences as the newest member joining its Critical Path for Parkinson’s Consortium
AcureX is a pharmaceutical company on a mission to stop major neurodegenerative diseases before they start, with an initial focus on Parkinson’s disease. To achieve this, AcureX leverages a first-in-class peripheral drug-responsive biomarker assays to molecularly define and segment patients in combination with novel disease-modifying therapeutics. AcureX is ushering in a new era of precision medicine... -
July 18, 2023
C-Path Integrates European Offices to Optimize Global Operations and Collaborative Partnerships
C-Path ts activity in Europe and broaden its global operations. C-Path operates in Europe as a nonprofit organisation that builds consensus among its stakeholders from around the world to improve public health. The organisation shares expertise, data, risks and costs to move regulatory science forward.